Faculty profile

Réjean Thomas

ResearcherMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.

Réjean Thomas

Researcher

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
2 publications in the last five years, latest in 2025.
Principal investigator on 1 research grant (1 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

At-Risk Populations Canada Chlamydia Trachomatis Diagnostics Digital Screening Strategies Multiple Pathogen Screening Multiplexed Testing Neisseria Gonorrhoeae

Latest papers

A prospective multi-site study to evaluate the performance and usability of an oral fluid-based HIV self-test in Canada.
BMC public health · 2025
Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO study.
BMJ open · 2023
Clinical and demographic predictors of antiretroviral efficacy in HIV-HBV co-infected patients.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2021

All 5 publications

Latest funding

Evaluating the Implementation and Real-World Effectiveness of Statin-Based Cardiovascular Primary Prevention in Routine HIV Care
CIHR · 2026 · Co-investigator
$822,376
Informing the roll-out of next generation HIV pre-exposure prophylaxis products: the impacts of person-centered approaches on HIV elimination and health inequities
CIHR · 2025 · Co-investigator
$100,000
Bridging surveillance, modeling, and implementation to close service gaps and end HIV risk among migrants
CIHR · 2025 · Co-investigator
$1,334,925

All 18 grants and awards

5 publications.

A prospective multi-site study to evaluate the performance and usability of an oral fluid-based HIV self-test in Canada.

Galli RA, Maraj D, McBain K, Lo Hog Tian JM, McFarland A, Tharao W, Nkala NP, Chan A, da Silva M, Thomas R, Vassal AF, Lepage M, Ireland L, Payne M, Starr J, Fraser C, Selfridge M, Loutfy M, Halpenny R, Jeyarajah N, Tran V, Mazzulli T, Rourke SB

BMC public health2025

DOI: 10.1186/s12889-024-21228-8 PMID: 39794710

Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO study.

Royston L, Isnard S, Berini CA, Bu S, Lakatos PL, Bessissow T, Chomont N, Klein M, Lebouché B, de Pokomandy A, Kronfli N, Costiniuk CT, Thomas R, Tremblay C, Boivin G, Routy JP

BMJ open2023

DOI: 10.1136/bmjopen-2022-067640 PMID: 36690406

Clinical and demographic predictors of antiretroviral efficacy in HIV-HBV co-infected patients.

Rana U, Driedger M, Sereda P, Pan S, Ding E, Wong A, Walmsley S, Klein M, Kelly D, Loutfy M, Thomas R, Sanche S, Kroch A, Machouf N, Roy-Gagnon MH, Hogg R, Cooper CL

Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada2021

DOI: 10.3138/jammi-2020-0011 PMID: 36341035

Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada?

Rana U, Driedger M, Sereda P, Pan S, Ding E, Wong A, Walmsley S, Klein M, Kelly D, Loutfy M, Thomas R, Sanche S, Kroch A, Machouf N, Roy-Gagnon MH, Hogg R, Cooper CL, Canadian Observational Cohort (CANOC) Collaboration

BMC infectious diseases2019

DOI: 10.1186/s12879-019-4617-8 PMID: 31752729

Tenofovir and emtricitabine resistance among antiretroviral-naive patients in the Canadian Observational Cohort Collaboration: implications for PrEP.

Younger J, Raboud J, Szadkowski L, Harrigan R, Walmsley S, Bayoumi AM, Klein MB, Cooper C, Burchell AN, Loutfy M, Hull M, Wong A, Thomas R, Hogg R, Montaner J, Tsoukas C, Antoniou T, Canadian Observational Cohort Collaboration

Antiviral therapy2019

DOI: 10.3851/imp3302 PMID: 30873953

Something wrong or missing on this profile? Suggest a correction

Réjean Thomas

Research

Latest papers

Latest funding

A prospective multi-site study to evaluate the performance and usability of an oral fluid-based HIV self-test in Canada.

Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO study.

Clinical and demographic predictors of antiretroviral efficacy in HIV-HBV co-infected patients.

Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada?

Tenofovir and emtricitabine resistance among antiretroviral-naive patients in the Canadian Observational Cohort Collaboration: implications for PrEP.

Frequent collaborators

Mona Loutfy

Robert Hogg

Sharon Walmsley

Marina Klein

Robert Hogg

Deborah Kelly

Abigail Kroch

Nicolas Chomont

Talat Bessissow

Julio Montaner

Jean-Pierre Routy

Mark Hull

Mona Loutfy

Guy Boivin

Martin Lepage

Marina Klein

Sharon Walmsley

Alexandra de Pokomandy

Wangari Tharao

Nicolas Chomont

Marie-Hélène Roy-Gagnon

Nadine Kronfli

Tony Mazzulli